论文信息 - Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised c - 字舞流文

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised c

J. Ji | J. Suo | Yingwei Xue | L. Shen | Lianhai Zhang | Xiaotian Zhang | Chang-ming Huang | C. Dang | Yong Li | Huimian Xu | Lin Chen | Zhongtao Zhang | G. Xiao | Ziyu Li | Xiaojiang Wu | Z. Bu | Yihong Sun | Leping Li | H. Liang | Yulong He | A. Wu | Yanbing Zhou | X. Ying | Xin Wang | P. Yu | Yanong Wang | Y. Bai | Huan-qiu Chen | C. Qi | Xin-bao Wang | G. Zhu | B. Jia | J. E | Yi-an Du | M. Cui | X. Su | Ji-ren Yu | Lin Chen | Zhiwei Zhou | Fei Li | Guoli Li | Dan Wu | Li Chen | Y. Ye | Yannan Yuan | C. Yao | Jiren Yu | Xin Yu Wang | Xinbao Wang | Zhiwei Zhou | Chang-ming Huang